Williams K M, Duffield A M, Christopher R K, Finlayson P J
Biomed Mass Spectrom. 1981 Apr;8(4):179-82. doi: 10.1002/bms.1200080410.
A new minor metabolite of 5-fluorocytosine, 5-hydroxy-5-fluorocytosine, was found in the urinary gravel excreted by a patient being treated with this drug. A metabolite of 5-fluorocytosine in animals, alpha-fluoro-beta-alanine, was identified and quantitated in the urine of nine patients. In general, alpha-fluoro-beta-alanine represented 0.05--0.25% of the daily dose of 5-fluorocytosine, both for orally and intravenously administered drug. Minor metabolites have been implicated in the occasional toxicity observed in patients receiving 5-fluorocytosine.
在一名接受5-氟胞嘧啶治疗的患者排出的尿结石中发现了一种新的5-氟胞嘧啶次要代谢产物,即5-羟基-5-氟胞嘧啶。在动物体内5-氟胞嘧啶的一种代谢产物α-氟-β-丙氨酸,在9名患者的尿液中得到了鉴定和定量。一般来说,无论是口服还是静脉给药,α-氟-β-丙氨酸占5-氟胞嘧啶日剂量的0.05%至0.25%。在接受5-氟胞嘧啶治疗的患者中偶尔观察到的毒性可能与次要代谢产物有关。